Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

Clinical trial NCT06832514 · RECRUITING

Trial details

NCT number: NCT06832514
Sponsor: University Ghent
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Meningococcal Meningitis, Serogroup B Transgender Persons Sex Differences in Immune Response Vaccination

Start date: 2025-01-31
Primary completion: 2026-07-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.